Group-Based Psychological Treatments Over Video Conference for Older Veterans With Chronic Pain (GPTVTCOVCP)

September 19, 2025 updated by: VA Office of Research and Development

Evaluating Group-Based Psychological Treatments Over Home Video Teleconference for Older Veterans With Chronic Pain

This study is being performed to compare the effects of three types of group-based psychological treatments delivered over video telehealth for chronic musculoskeletal pain in older U.S. military Veterans. The three types of psychological treatments are: Cognitive-Behavioral Therapy (CBT), Emotional Awareness and Expression Therapy (EAET), and Mindfulness Meditation (MM). In addition, the investigators will evaluate which patients respond best to each treatment and how each treatment works.

The investigators are performing the study because chronic pain is a big problem among Veterans. Older Veterans are the focus because they have the highest rates of chronic pain, perhaps as high has 80%. The investigators are looking at psychological treatments because they are less risky than medications or procedures for older Veterans. Telehealth is an important aspect of the proposal, as delivery over telehealth could improve access to treatments. CBT is endorsed nationally by VA, but no standardized MM is available through VA, and only a few VA sites use EAET, which is a newer treatment focusing on how stress and emotions affect pain. The project aims to evaluate a standardized form of MM and the newer treatment, EAET, compared to the standard CBT used widely in VA.

Study Overview

Detailed Description

The overarching goal of the proposed research is to learn how to optimize group-based psychological treatments for chronic pain delivered over video telehealth to the homes of older Veterans. Chronic pain is a critical healthcare challenge for VA, because the condition affects 50% of Veterans and is notoriously difficult to treat. Older Veterans are affected with chronic pain even more commonly and severely than younger Veterans, and older Veterans are more susceptible to side effects from pain medications and invasive procedures. Psychological chronic pain treatments do not usually have severe side effects, but tend to produce only modest benefits. To increase the effectiveness of psychological treatments, VA experts have recommended testing standardized treatments with larger and more durable benefits, testing group and video telehealth delivered treatments to improve access, identifying mechanisms of response so that the most powerful mechanisms may be targeted, and determining what Veteran characteristics may predict response to the various treatment options. The proposed randomized clinical trial will address all the recommendation of VA experts. First, the project will evaluate the effects of standardized formats of Mindfulness Meditation (MM) and Emotional Awareness and Expression Therapy (EAET) compared to the VA standard psychological chronic pain treatment, Cognitive Behavioral Therapy (CBT). Many Veterans are interested in MM, but a standardized protocol so far has not been established. EAET is a newer treatment that addresses painful stress and emotions to reduce or eliminate chronic pain. These two approaches are hypothesized to have larger benefits than CBT. Second, the project will deliver all treatments in groups and over video telehealth to the homes of Veterans to enhance access. Third, the project will test shared and specific (unique) mechanisms of response for each treatment. Fourth, the project will evaluate a set of demographic and clinical characteristics (e.g., trauma history) to see whether Veterans with certain characteristics are more likely to respond to one treatment or another. The Investigators plan to enroll up to 216 multi-ethnic/multi-racial older Veterans (age 60-95 years) with chronic musculoskeletal pain at VA Greater Los Angeles Healthcare System and VA Connecticut Healthcare System.

Study Type

Interventional

Enrollment (Estimated)

216

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Karin C Liu, MPH
  • Phone Number: 40515 (310) 478-3711
  • Email: karin.liu@va.gov

Study Locations

    • California
      • West Los Angeles, California, United States, 90073-1003
        • Recruiting
        • VA Greater Los Angeles Healthcare System, West Los Angeles, CA
        • Principal Investigator:
          • Brandon C Yarns, MD MS BME
        • Contact:
        • Contact:
        • Sub-Investigator:
          • David Avram Ganz, MD PhD MPH
    • Connecticut
      • West Haven, Connecticut, United States, 06516-2770
        • Recruiting
        • VA Connecticut Healthcare System West Haven Campus, West Haven, CT
        • Contact:
        • Sub-Investigator:
          • Mary Driscoll, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Eligible individuals are

  • Veterans;
  • age 60-95 years;
  • have at least 3 months of musculoskeletal pain, including the following conditions: back, neck, leg, or pelvic pain; temporomandibular joint disorders; fibromyalgia; tension headaches; or any combination of these disorders; and
  • have an average daily pain intensity of at least 4 on a 0 to 10 scale.

Exclusion Criteria:

  • pain conditions likely to respond pharmacologic or surgical treatment only when they are the primary or sole complaint: hip or knee osteoarthritis, leg pain greater than back pain (to exclude radiculopathy), electromyography-confirmed "tunnel" syndromes (e.g., carpal tunnel syndrome), gout, neuralgias, migraine, and cluster headaches;
  • non-musculoskeletal pain conditions: autoimmune disease that typically generates pain (e.g., rheumatoid arthritis), cancer pain, sickle cell disease, burn pain, infection associated with pain, and cauda equina syndrome; and
  • these conditions or circumstances: severe psychiatric disorder such as schizophrenia or bipolar I disorder not controlled with medications, active suicide or violence risk, active severe alcohol or substance use disorder, substantial cognitive impairment or dementia (assessed using telephone Mini-Mental State Examination (tMMSE) score <19), previously completed EAET, CBT-CP, or MM/MBSR, currently enrolled in another psychological pain treatment, currently in pain-related litigation or applying for pain-related compensation or compensation increase, unable to fluently read or converse in English, no home internet access.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Emotional Awareness and Expression Therapy
Seeks to reduce physical (e.g., pain) and emotional (e.g., depression, anxiety) symptoms by helping individuals become aware of their emotions, express them, and resolve emotional conflicts. It will use techniques such as writing about stress, role playing how to handle difficult relationships, recognizing and expressing anger and other feelings, and being more open with others.
Seeks to reduce physical (e.g., pain) and emotional (e.g., depression, anxiety) symptoms by helping individuals become aware of their emotions, express them, and resolve emotional conflicts. It will use techniques such as writing about stress, role playing how to handle difficult relationships, recognizing and expressing anger and other feelings, and being more open with others.
Other Names:
  • EAET
Experimental: Mindfulness Meditation
Seeks to help individuals achieve present moment awareness, self-compassion, and acceptance of chronic pain. It will use techniques such as the body scan, grounding, mindful breathing, mindful walking, loving kindness, and compassionate breathing.
Seeks to help individuals achieve present moment awareness, self-compassion, and acceptance of chronic pain. It will use techniques such as the body scan, grounding, mindful breathing, mindful walking, loving kindness, and compassionate breathing.
Other Names:
  • MM
Active Comparator: Cognitive Behavioral Therapy
Seeks to help individuals function better and improve symptoms by teaching various cognitive and behavioral skills to manage symptoms. It will use techniques such as relaxation training, engaging in pleasant activities, pacing yourself, and changing unhelpful ways of thinking.
Seeks to help individuals function better and improve symptoms by teaching various cognitive and behavioral skills to manage symptoms. It will use techniques such as relaxation training, engaging in pleasant activities, pacing yourself, and changing unhelpful ways of thinking.
Other Names:
  • CBT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Pain Inventory: Mean Pain Severity
Time Frame: Change from baseline to 8 weeks
Average of 4 self report items: current pain, worst pain over the last 7 days, least pain over the last 7 days, and average pain over the last 7 days. Each item is scored 0-10 (0 = no pain; 10 = pain as bad as can be), yielding a total score between 0 and 10.
Change from baseline to 8 weeks
Brief Pain Inventory: Mean Pain Severity
Time Frame: Change from baseline to 20 weeks
Average of 4 self report items: current pain, worst pain over the last 7 days, least pain over the last 7 days, and average pain over the last 7 days. Each item is scored 0-10 (0 = no pain; 10 = pain as bad as can be), yielding a total score between 0 and 10.
Change from baseline to 20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Pain Inventory: Pain Interference
Time Frame: Change from baseline to 8 weeks
Average of 7 self report items on interference of pain with daily activities over the last 7 days: general activity, walking, work, mood, enjoyment of life, relations with others, and sleep. Each item is scored 0-10 (0 = does not interfere; 10 = completely interferes), yielding a total score between 0 and 10.
Change from baseline to 8 weeks
Brief Pain Inventory: Pain Interference
Time Frame: Change from baseline to 20 weeks
Average of 7 self report items on interference of pain with daily activities over the last 7 days: general activity, walking, work, mood, enjoyment of life, relations with others, and sleep. Each item is scored 0-10 (0 = does not interfere; 10 = completely interferes), yielding a total score between 0 and 10.
Change from baseline to 20 weeks
Patient Health Questionnaire-8
Time Frame: Change from baseline to 8 weeks
Sum of 8 self report items assessing depression and emotional distress over the last 2 weeks. Items range from 0-3 (0 = not at all; 3 = nearly every day) for a total score between 0 and 24.
Change from baseline to 8 weeks
Patient Health Questionnaire-8
Time Frame: Change from baseline to 20 weeks
Sum of 8 self report items assessing depression and emotional distress over the last 2 weeks. Items range from 0-3 (0 = not at all; 3 = nearly every day) for a total score between 0 and 24.
Change from baseline to 20 weeks
PTSD Checklist for DSM-5
Time Frame: Change from baseline to 8 weeks
Sum of 20 self report items assessing post-traumatic stress disorder symptoms over the last month. Items range from 0-4 (0 = not at all; 3 = extremely) for a total score between 0 and 80.
Change from baseline to 8 weeks
PTSD Checklist for DSM-5
Time Frame: Change from baseline to 20 weeks
Sum of 20 self report items assessing post-traumatic stress disorder symptoms over the last month. Items range from 0-4 (0 = not at all; 3 = extremely) for a total score between 0 and 80.
Change from baseline to 20 weeks
Patient's Global Impression of Change
Time Frame: 8 weeks
Patient rates on a single item with a scale of 1-7 the change (if any) they've experienced since beginning treatment in the study (1 = no change or condition has worsened; 7 = a great deal better and a considerable improvement that has made all the difference).
8 weeks
Patient's Global Impression of Change
Time Frame: 20 weeks
Patient rates on a single item with a scale of 1-7 the change (if any) they've experienced since beginning treatment in the study (1 = no change or condition has worsened; 7 = a great deal better and a considerable improvement that has made all the difference).
20 weeks
Generalized Anxiety Disorder 7-item
Time Frame: Change from baseline to 8 weeks
Sum of 7 self report items assessing anxiety and worrying over the last 2 weeks. Items range from 0-3 (0 = not at all; 3 = nearly every day) for a total score between 0 and 21.
Change from baseline to 8 weeks
Generalized Anxiety Disorder 7-item
Time Frame: Change from baseline to 20 weeks
Sum of 7 self report items assessing anxiety and worrying over the last 2 weeks. Items range from 0-3 (0 = not at all; 3 = nearly every day) for a total score between 0 and 21.
Change from baseline to 20 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic Pain Acceptance Questionnaire-2 Item
Time Frame: Change from baseline to 4 weeks
Sum of two self report items assessing the subject's acceptance of chronic pain. Items range from 0-6 (0 = never true; 6 = always true), yielding a total score between 0 and 12.
Change from baseline to 4 weeks
Chronic Pain Acceptance Questionnaire-2 Item
Time Frame: Change from baseline to 8 weeks
Sum of two self report items assessing the subject's acceptance of chronic pain. Items range from 0-6 (0 = never true; 6 = always true), yielding a total score between 0 and 12.
Change from baseline to 8 weeks
Chronic Pain Acceptance Questionnaire-2 Item
Time Frame: Change from baseline to 20 weeks
Sum of two self report items assessing the subject's acceptance of chronic pain. Items range from 0-6 (0 = never true; 6 = always true), yielding a total score between 0 and 12.
Change from baseline to 20 weeks
Self-Compassion Scale-Short Form
Time Frame: Change from baseline to 4 weeks
Sum of twelve self report items assessing the subject's feelings of self-compassion. Items range from 1-5 (1 = almost never; 6 = almost always), yielding a total score between 12 and 60.
Change from baseline to 4 weeks
Self-Compassion Scale-Short Form
Time Frame: Change from baseline to 8 weeks
Sum of twelve self report items assessing the subject's feelings of self-compassion. Items range from 1-5 (1 = almost never; 6 = almost always), yielding a total score between 12 and 60.
Change from baseline to 8 weeks
Self-Compassion Scale-Short Form
Time Frame: Change from baseline to 20 weeks
Sum of twelve self report items assessing the subject's feelings of self-compassion. Items range from 1-5 (1 = almost never; 6 = almost always), yielding a total score between 12 and 60.
Change from baseline to 20 weeks
Life Events Checklist for DSM-5
Time Frame: Baseline
Self report checklist on whether 17 potentially traumatic and life threatening events occurred (yes/no) in the subject's life.
Baseline
Emotional Approach Coping Scales
Time Frame: Change from baseline to 4 weeks
Sum of four self-report items assessing whether the subject uses an emotional approach to coping when experiencing stress or difficulties. Items range from 1-4 (1 = I don't use this emotional coping strategy; 4 = I use this emotional coping strategy a lot), yielding a total score between 4 and 16.
Change from baseline to 4 weeks
Emotional Approach Coping Scales
Time Frame: Change from baseline to 8 weeks
Sum of four self-report items assessing whether the subject uses an emotional approach to coping when experiencing stress or difficulties. Items range from 1-4 (1 = I don't use this emotional coping strategy; 4 = I use this emotional coping strategy a lot), yielding a total score between 4 and 16.
Change from baseline to 8 weeks
Emotional Approach Coping Scales
Time Frame: Change from baseline to 20 weeks
Sum of four self-report items assessing whether the subject uses an emotional approach to coping when experiencing stress or difficulties. Items range from 1-4 (1 = I don't use this emotional coping strategy; 4 = I use this emotional coping strategy a lot), yielding a total score between 4 and 16.
Change from baseline to 20 weeks
Pain/Brain Attributions Scale
Time Frame: Change from baseline to 4 weeks
Sum of five self-report items assessing whether the subject beliefs about whether pain is related to stress, brain changes, or emotions. Items range from 0-4 (0 = strongly disagree; 4 = strongly agree) for a total score between 0 and 20.
Change from baseline to 4 weeks
Pain/Brain Attributions Scale
Time Frame: Change from baseline to 8 weeks
Sum of five self-report items assessing whether the subject beliefs about whether pain is related to stress, brain changes, or emotions. Items range from 0-4 (0 = strongly disagree; 4 = strongly agree) for a total score between 0 and 20.
Change from baseline to 8 weeks
Pain/Brain Attributions Scale
Time Frame: Change from baseline to 20 weeks
Sum of five self-report items assessing whether the subject beliefs about whether pain is related to stress, brain changes, or emotions. Items range from 0-4 (0 = strongly disagree; 4 = strongly agree) for a total score between 0 and 20.
Change from baseline to 20 weeks
Coping Strategies Questionnaire
Time Frame: Change from baseline to 4 weeks
Sum of six self-report items assessing the subject's use of coping strategies. Items range 0-6 (0 = never use this strategy; 6 = always use this strategy). Two-item subscales (catastrophizing, increased behavioral activities, cognitive coping) are scored separately, yielding total scores between 0 and 12.
Change from baseline to 4 weeks
Coping Strategies Questionnaire
Time Frame: Change from baseline to 8 weeks
Sum of six self-report items assessing the subject's use of coping strategies. Items range 0-6 (0 = never use this strategy; 6 = always use this strategy). Two-item subscales (catastrophizing, increased behavioral activities, cognitive coping) are scored separately, yielding total scores between 0 and 12.
Change from baseline to 8 weeks
Coping Strategies Questionnaire
Time Frame: Change from baseline to 20 weeks
Sum of six self-report items assessing the subject's use of coping strategies. Items range 0-6 (0 = never use this strategy; 6 = always use this strategy). Two-item subscales (catastrophizing, increased behavioral activities, cognitive coping) are scored separately, yielding total scores between 0 and 12.
Change from baseline to 20 weeks
Working Alliance Inventory
Time Frame: Change from baseline to 4 weeks
Sum of three self-report items assessing the subject's thoughts and feelings on their therapist. Items range 1-7 (1 = never; 4 = sometimes; 7 = always), yielding a total score between 3 and 21.
Change from baseline to 4 weeks
Working Alliance Inventory
Time Frame: Change from baseline to 8 weeks
Sum of three self-report items assessing the subject's thoughts and feelings on their therapist. Items range 1-7 (1 = never; 4 = sometimes; 7 = always), yielding a total score between 3 and 21.
Change from baseline to 8 weeks
Working Alliance Inventory
Time Frame: Change from baseline to 20 weeks
Sum of three self-report items assessing the subject's thoughts and feelings on their therapist. Items range 1-7 (1 = never; 4 = sometimes; 7 = always), yielding a total score between 3 and 21.
Change from baseline to 20 weeks
Pain Self-Efficacy Questionnaire-2 item
Time Frame: Change from baseline to 4 weeks
Sum of two self-report items assessing the subject's confidence in performing activities of daily living despite pain. Items range 0-6 (0 = not at all confident; 6 = completely confident), yielding a total score between 0 and 12.
Change from baseline to 4 weeks
Pain Self-Efficacy Questionnaire-2 item
Time Frame: Change from baseline to 8 weeks
Sum of two self-report items assessing the subject's confidence in performing activities of daily living despite pain. Items range 0-6 (0 = not at all confident; 6 = completely confident), yielding a total score between 0 and 12.
Change from baseline to 8 weeks
Pain Self-Efficacy Questionnaire
Time Frame: Change from baseline to 20 weeks
Sum of two self-report items assessing the subject's confidence in performing activities of daily living despite pain. Items range 0-6 (0 = not at all confident; 6 = completely confident), yielding a total score between 0 and 12.
Change from baseline to 20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brandon C Yarns, MD MS BME, VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

August 16, 2023

First Submitted That Met QC Criteria

August 16, 2023

First Posted (Actual)

August 22, 2023

Study Record Updates

Last Update Posted (Actual)

September 22, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Datasets that meet VA standards for disclosure to the public will be made available within 1 year of publication. Prior to their distribution, a local privacy officer will certify that all datasets contain no PHI. Final datasets will be maintained locally until enterprise-level resources become available for long-term storage and access. Guidance on request and distribution processes will be provided by ORD. Those requesting datasets will be asked to sign a Letter of Agreement.

IPD Sharing Time Frame

Datasets that meet VA standards for disclosure to the public will be made available within 1 year of publication. The analytical datasets and statistical code used in publications will be retained for 6 years, in accordance with VA record retention policy.

IPD Sharing Access Criteria

Datasets that meet VA standards for disclosure to the public will be made available within 1 year of publication. The analytical datasets and statistical code used in publications will be retained for 6 years, in accordance with VA record retention policy.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Musculoskeletal Pain

Clinical Trials on Emotional Awareness and Expression Therapy

Subscribe